cowtown jay
13 hours ago
"Sanofi reports two operating segments: Biopharma and Opella (formerly Consumer Healthcare β CHC).
The Biopharma operating segment comprises commercial operations and research, development and production activities relating to the Speciality Care, General Medicines and Vaccines franchises, for all geographical territories. The segmentβs results include the costs of global support functions that are not within the managerial responsibility of the Opella GBU.
The Opella operating segment comprises commercial operations relating to consumer healthcare products, and research, development and production activities and global support functions (as listed above) dedicated to the segment, for all geographical territories. The Opella GBU segmentβs results reflect all incurred costs of global support functions attributable to its business."
see pg 45,
D.1.1. OPERATING SEGMENTS
https://www.sec.gov/Archives/edgar/data/1121404/000112140424000016/exhibit992-2024halfyearman.htm
The Biopharma segment may be more geared to incorporating entities like Humanigen/Taran.
US-JUSTICE
1 day ago
These EXPENSE reports is mainly for the debtor as a company in 'bankruptcy' has to get court approval to spend any money.
Here is the reality, before the bankruptcy, the company had 2-3 million in cash and accounts receivables.
as of now, it has less than 300,000 in cash. so in company that is bankrupt and owes small vendors $2000 or $1000 and not paying bills, somehow it has spent $2 million in 'legals fees' to go bankrupt and not pay creditors a dime. is that justice? The company has no cash left and has no money to pay of it's lawyers. it cannot even pay any of it's employees, Why waste money in declaring bankruptcy. For most bankrupt companies, the owners just bail leave the country and don't bother with bankruptcy court. There is nothing the creditors can do if the owners of a company just takes all the money and sells everything and just close the doors and wire all the money out. But in this case, humanigen had and own assets it needed to transfer out. For the Dale, and the employees, they are just employees and not liable for anything same with employees. As for creditors who claim they are owe money. who cares, your problem of the 40 million 'claim' 95% of the money if fake claims and they didn't lose anything and humanigen owes these FAKE creditors claim nothing and should pay nothing and will not pay anything as the creditors are the 'criminals' in this case.
cowtown jay
1 day ago
I feel ya, dlog. I won't be doing any travel, either, as long as Social Security remains my sole source of income, and I can't supplement that with trading profits, as I was doing, until we had to change the track we were on.
But, to me, nothing I see indicates that our destination has changed. Still, I believe that we have never been stronger than we are now. And I can't over-emphasize what I see as the developing need for lenz. Consider evidence of that:
"The south Indian state of Kerala is battling an outbreak of Nipah: a virus that comes from bats, but which has triggered multiple human outbreaks in recent decades. The World Health Organization (WHO) lists Nipah as one of its priority pathogens: those with high epidemic potential, and for which zero or insufficient countermeasures exist. The virus is also considered a bioterrorism threat...
Before the current outbreak in India, a total 634 cases and 376 deaths had been recorded worldwide...
Also, whereas mortality during the first Bangladesh outbreak in 2001 was 69%, during the 2013 outbreak it was 83%, while an outbreak in Kerala, India in 2018 killed 17 out of the 18 people infected β a fatality rate of 94.4%...
The Bangladesh strain is associated with additional symptoms, including muscle weakness, cough and breathing difficulties and can be transmitted directly between humans, through contact with body fluids and possibly respiratory droplets produced when people cough or sneeze. The 2018 outbreak in Kerala was associated with a further symptom: heart muscle dysfunction...
Studies on the spread of Nipah virus in Bangladesh have suggested that human-to-human transmission occurs through direct contact with patients and their body secretions, such as urine, blood, and nasal or respiratory droplets. Such infections have usually occurred in hospitals among healthcare staff, caregivers or visitors, although transmission within households is also believed to have occurred...
https://www.gavi.org/vaccineswork/seven-things-you-need-know-about-nipah-virus?gad_source=1&gclid=CjwKCAjw74e1BhBnEiwAbqOAjBXEbsbh042OGVV5EmDfa0EbdCNDNqfI5euPrN3YqMrOAbQl9YbjjxoCwcAQAvD_BwE
But, have no fear. Five months after the Nipah outbreaks, selected legislators convened in a Sensitive Compartmented Information Facility (SCIF) to discuss national security issues, which hopefully included this potentially actively-unfolding pandemic, as well as other developing threats.
"Mike Johnson Urges Calm After Republican Discloses Mysterious 'National Security Threat'
Arthur Delaney
Updated February 14, 2024"
https://www.yahoo.com/news/mike-johnson-urges-calm-republicans-192533613.html
Even though members of the Hope Accord have called for a ban on mRNA vaccines, "Vaccines are being developed against (Nipah). While there are currently no approved human vaccines or treatments for Nipah, several are currently in clinical trials, including an mRNA-based vaccine, one based on a protein from the closely related Hendra virus and another that uses a harmless vesicular stomatitis virus to deliver a Nipah virus protein." We can only hope that the protein-based vaccine, such as made by Sanofi for Novavax, and enhanced with the lenz cocktail, will be selected as the Standard of Care to prevent this potential pandemic, as well as using lenz to treat infected patients, whether hospitalized or on an outpatient basis while their CRP levels are low.
cowtown jay
2 days ago
I don't think Taran acquired all of the Humanigen patents. This bankruptcy case is going to be closed out, with all creditors paid, and our merged entity could continue to use what will be the well-capitalized shell, which we'll quickly relist on the OTC with our new ticker, until Nasdaq requirements are met again. Given our share structure, regaining Nasdaq compliance won't take long. The delinquent filings have probably been completed for some time, if that will be necessary.
cowtown jay
2 days ago
It's gonna be kinda hard to make the case that Taran stole the IP from Humanigen and the shareholders, when they do a stock-for-stock (or a 5:1) merger with us. And if it does prove to be a 5:1 merger, that will only be because the entity we form with Taran, will do a further merger with Sanofi and/or Novavax, which will result in the creation of another new entity, jointly owned by HOT, Sanofi, and/or Novavax.
That's exactly the kind of justification the bankruptcy court judge would have amended the Asset Purchase Agreement to accommodate.
cowtown jay
2 days ago
Didn't we, at one time, talk about Florence and Pisa, and the Alps? I remember trying to buy Italian Ice in a local shop, and was very grateful for the translational help I got from a young American lady, living in an Italian villa that her father had bought. I didn't go further south than Pisa, so I never got to Malta, just south of Italy. But Switzerland is beautiful, just north of Italy. If I'm lucky with this investment, maybe I'll go back to the the Oberammergau part of Garmisch-Partenkirchen, and to Austria, and import crystal, wood and candle carvings, and Steifel and Goebel porcelain figurines. Maybe my daughter will appreciate owning a gift shop and not having a boss.
It's a beautiful part of the world, and relocating ex-pats and investment migrants is a cottage industry.
https://www.henleyglobal.com/services/private-clients
If I was Dale, I'd spend summer in Switzerland, and winters in Malta.
But, we basically have more and more people, here in the States, moving into new States where their values are more broadly integrated into everyday life. That most certainly applies to me, and my choice to live in Texas, and rural Texas, at that, and in what I actually consider the Republic of Texas, with my own Alamo.
Dale is fortunate enough to have the lifestyle he wants. There's no more reason to disparage him for his decision, than there is to disparage me for mine. I think we both made moves in accordance with our abilities and desires. I'm glad as hell, when my enlistment was up, I left my duty assignment in Germany, and did not go back to Youngstown, Ohio. I don't think I'd like posting as "rust bucket jay."
cowtown jay
3 days ago
With SpongeTech, I focused on the SEC and FINRA.
Here, as soon as I saw how the share structure was designed, I knew it would be pointless for me to worry about those agencies. I believed that management was defending us appropriately and effectively against them. Besides, the FDA, the NIH, and NIAID gave us plenty to question. And the spotlight on them has just continued to shine brighter, with us gaining pharmaceutical partnering interest, as well as overall media and legislative interest increasing in regards to the safety and efficacy of the institutionalized covid prevention and treatment protocols. I am confident we will prevail in getting lenz approved and commercialized on a worldwide scale. I only hope to be able to re-enter my $200 sell orders at the right time when our trading resumes.
I think the time has arrived to finally deal with the SEC. The fact that we are doing so in mediation, versus a continued Litigation Release or Admin Proceeding, I think signifies less SEC interest in continuing to try to prosecute this case, which has likely proven not be be what they thought it was.
RitonavirCYP3A4
3 days ago
Jay, in order to put your incorrect assumptions to rest: HGEN in their latest 10-Q had 119,080,135 shares outstanding
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001293310/000121465923007002/hgen-20230331.htm
When Crooked Dale's last crooked sales of shares were done, he had ~11 million shares remaining spread out between Black Horse and Cheval, making him <10% owner.
https://www.sec.gov/Archives/edgar/data/1293310/000101359423000819/xslF345X05/form4.xml
Keep on dreaming, friend. My bet is on SEC taking Dale et al to the cleaners.
Didn't some guy on here have 4 million shares he bought luckily on sale? LOL
cowtown jay
3 days ago
If the Black Horse entities owned the majority of Humanigen's shares, as we agree that they did, that likely had a huge negative impact on SEC charges. How many small cap biotech management teams can manage to gain control of 65 - 90% of the shares they have issued? AND, get a hugely successful Phase III trial on a novel coronavirus completed within one year, while continuing their in-process trials on CMML, along with their companion trial on aGvHD, which, together, promise to eradicate several leukemias, and prevent stem cell transplant and CAR-T toxicities?
cowtown jay
3 days ago
Thanks for taking the time to write that post, sosjtb. It's surprising that there is that degree of latitude in how brokerages can report in this instance. It's clear that we can be sure that HGEN shares were canceled. But were there any shares to be canceled, or had the shares already been transferred in advance of a merger with Taran? And why engage Geoff Winkler as the receiver of the Black Horse assets? He was also the Authorized Person for making the Form 4 filings for the Black Horse entities on Oct 10, 2023.
https://www.sec.gov/Archives/edgar/data/1178179/000101359423000819/xslF345X05/form4.xml
I think we have to look at the District and Appellate cases. It appears that the Appeals Court decision was just made on the 9th of July, 2024. I sense that this decision resulted favorably, and that management is less constrained than they may have been.
https://www.pacermonitor.com/public/case/50820730/SEC_v_Dale_Chappell,_et_al
But it looks like the District Court case is still ongoing. A status conference that was scheduled yesterday was adjourned. A new status conference is scheduled on 10/15/2024, if this case isn't settled by mediation before then. I would have hoped that the Appeals Court decision would have settled the District Court issues, but it evidently hasn't. The documents in this case remain sealed. And an amended mediation referral order was signed on July 11, 2024.
"AMENDED MEDIATION REFERRAL ORDER: The Clerk of Court shall terminate retired-Judge FAITH HOCHBERG as mediator in this matter. The parties are referred to private mediation before retired-Judge JOSE L. LINARES. The parties shall complete mediation on or before 9/30/2024."
https://www.pacermonitor.com/public/case/52335094/SECURITIES_AND_EXCHANGE_COMMISSION_v_CHAPPELL_et_al
If I am right that the Appeals Court case was concluded, and that we are down to a private mediation at the District Court level, I hope that we can settle well before the deadline, and then enter into our restructuring agreements with our partners. I was pleased to see Geoff appointed as the receiver of the Black Horse assets after all the time he has put into this effort.
sosjtb
3 days ago
Jay I have HGEN shares in two accounts. My Etrade shows account shows 100% loss value at $0.
My Schwab account shows a value based on the price per share of just over a penny based on the last closing price before they got kicked to the curb on the EM.
Itβs a technicality, the shares are worthless. Durrant and Chappell have no fiduciary reason whatsoever to hand over shares in Tarran or any other company to HGEN shareholders. Morally maybe? But morals take a back seat to money and greed, and those two make the rules.
Itβs over, they got what they wanted, they made a shit ton of money selling stock and a massive pump and dump orchestrated by Blackhorse/Cheval.
They took what was of value to Tarran and when that goes public with Lenz approval, they will make even more money while we sit here in IHub shaking our fists and accepting that shareholders got screwed once again.
US-JUSTICE
4 days ago
HGENQ shares are now cancelled but get no message from broker. It's a new symbol. HGENQ ticker has been cancelled with no notifications etc.
No information from transfer agent or company management in SEC filings.
No notification from SEC
No notification from company
No notification from broker
No notification from transfer agent
nothing
Some companies don't even bother filing for bankruptcy and just not file SEC reports and get delisted and disappear. That is how regulated the stock market is. less regulated than some street vendor in the flea market. or craigslist. or some guy selling fake concert tickets. no legal recourse nothing.
When a company cancels its common stock, it declares all existing common stock certificates to be null and void. Most often, companies cancel stock when going through bankruptcy proceedings. After cancelling, the company may cease to exist or issue new shares in a reorganized company. In either instance, the cancelled shares only have value as souvenirs, not as securities.
Notification
A company can cancel common stock in bankruptcy and occasionally in other situations such as reverse stock splits, though a temporary recall is more common. The company may need authorization from a regulatory power before it can cancel, depending on where the company operates. It then instructs a financial service, called a transfer agent, to notify all investors, exchanges and other parties involved in the exchange of its common stock.
Certificates
The transfer agent notifies all relevant parties and updates databases so that all outstanding shares of common stock appear as "canceled." If an investor holds a paper certificate, the transfer agent may try to recall the certificate but can also simply update databases so that any search for the certificate number will show that it is no longer a valid stock certificate.
Meaning
A canceled share of common stock has no value as a security. The company no longer recognizes that share as representing ownership in the company and therefore other investors no longer recognize it as valuable.
Situations
Companies can cancel shares and not issue any more, which frequently happens in bankruptcy cases. Companies can also cancel existing shares of common stock and reissue new shares. In cases where common stock is reissued, the old shares have no value and no longer represent ownership, while the new shares do.
cowtown jay
4 days ago
"FDA not approving a drug that has potential to save millions of lives is the real crime..."
I agree.
But so do companies like Sanofi, Gracell/AstraZeneca, and Novavax. Entities like Mayo Clinic, IMPACT, and SAHMRI also likely agree. And as additional information regarding vaccine injuries and excess deaths comes to light, the worldwide medical community will all turn to lenz.
US-JUSTICE
5 days ago
Currently, the chapter 11 case is considered 'corporate law' and assumes no criminal activity like investment fraud, bankruptcy fraud, fake creditor claim 'FRAUD' . With so much investment fraud, people or crooks might think this is all legal since everybody is doing and getting away with it.
Corporate law is more of civil crimes like contract disputes, patent violations etc. defamation
where as CRIMINAL law is like ROBBERY, and theft where there is intent to steal via fraudulent actions.
The gov't has made many civil actions as felonies like insider trading, front running and has given the SEC a lot POWERS which it should not get or deserve. SEC has abuse it's POWERS that was given to it by the gov't or congress or the politicians or the people but somehow over the years have become corrupt and the SEC is now failed institution like many gov't institutions including congress and the whitehouse or presidents office.
there is no incentive not to commit investment fraud in the exchanges but an incentive to commit investment fraud. only a fool would not commit investment fraud. since they have the protection of the SEC to commit crimes like investment fraud.
cowtown jay
5 days ago
Did you notice that Taran doesn't address the covid indication anywhere on their site? Did you also see that I reported Taran was apparently not assigned the covid patents?
https://www.plainsite.org/patents/assignment.html?id=11607371
The covid information I linked was from "An investor's view: Pacific Royalties." The link was provided on Taran's 'The Opportunity' tab.
http://www.pacificroyalties.com/resources/taran-therapeutics/
That Executive Summary from Pacific Royalties also notes that Taran acquired Humanigen's Australian Subsidiary. In addition, the Executive Summary notes that, "When β not if β a new outbreak occurs, Taran will be among the first with the experience and resources to begin addressing that need quickly."
I've been discussing the complex merger activity of Inhibrx, prior to their becoming a subsidiary of Sanofi. I thought we could see similar activity, such as our merging with Humanigen Australia, then into Taran, which could be the end of the merging. However, if we see that Geoff has transferred our shares into either Taran or Humanigen Australia, we could see a forward split of 5:1 declared, and announce a further merger into a new entity co-owned by us and Sanofi and/or Novavax.
Savy, shrewd, and exactly what I would expect from this management team!
cowtown jay
5 days ago
"Many public health professionals are convinced that a new serious variant of the original COVID-19 source, will eventually emerge through mutation. By the end of 2023, a total of 772 million people worldwide had contracted COVID and its variants, and a new milestone was passed β 7 million fatalities worldwide (over 1.2 million in the US).
As of this writing (April 2023), people continue to die each day from COVID-19 and its mutations. Source: World Health Organization
Only disciplined application of monoclonal antibody therapies has kept these numbers from being much larger.
When β not if β a new outbreak occurs, Taran will be among the first with the experience and resources to begin addressing that need quickly."
https://www.tarantherapeutics.com/the-opportunity
As an aside, I found this interesting. "In early 2024, Taran acquired the assets of Humanigen, a NASDAQ-listed company, through a bankruptcy sale. These assets included LENZ, which had already been developed at a cost of more than $500 million." This is the second reference I have seen to a number greater than half a billion dollars.
cowtown jay
5 days ago
For context: "the possibility of illegal bio-labs springing up across the country, and what could intentionally result from that, is a very, very real threat, and only serves to illustrate the great need we have for products like lenz." (oakhill3)
For context: "the possibility of illegal bio-labs springing up across the country, and what could intentionally result from that, is a very, very real threat, and only serves to illustrate the great need we have for products like lenz. (oakhill3)— Jay Booth (@booth37337) July 21, 2024
cowtown jay
7 days ago
eb, you and I know how the market reacted to news of our topline data. I've said several times that I sold shares in the $27 and $29 range on the day of that news, which merely anticipated that the news would garner regulatory authorization.
Now we know that the bankruptcy judge has reason to be assured that lenz will get approved, because of his approval of the amended APA in regards to Milestones.
Further, we see that the Black Horse entities were stuffed full of Humanigen shares, as I thought they would be. And I always believed that these shares were controlled by the company.
So Humanigen, which I think may still own the non-CAR-T patents,* and which also owns the vast majority of the OS, could see a billion dollars+ in profit if they merged before the shares were canceled, whether with Taran, or with the entity leveraging the Sanofi/Novavax co-exclusive licensing and commercialization partnership.
We're seeing cash balances for our zero shares in our Humanigen accounts. I think our shares are just teed-up ahead of our pending merger.
Thank you for your sustained encouragement. I'm so caught-up in the narrative I developed after these years of trying to understand the obstacles management has had to navigate around, that I have no patience for alternative explanations that just don't seem to fit (even if they are somehow right).
*https://www.plainsite.org/patents/assignment.html?id=11607371